PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 97 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2023 | $7,569 | -97.5% | 45,737 | -85.0% | 0.00% | – |
| Q1 2023 | $298,218 | +116.1% | 305,552 | +130.3% | 0.00% | – |
| Q4 2022 | $137,980 | -4.2% | 132,673 | +5.7% | 0.00% | – |
| Q3 2022 | $144,000 | -38.7% | 125,477 | 0.0% | 0.00% | – |
| Q2 2022 | $235,000 | -38.2% | 125,477 | 0.0% | 0.00% | – |
| Q1 2022 | $380,000 | +12566.7% | 125,477 | +9552.1% | 0.00% | – |
| Q3 2020 | $3,000 | +200.0% | 1,300 | +225.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |